The Trump administration decided to put the pilot on hold until at least 2027.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
11h
GLP-1 Coverage For People On Medicare Is Shifting—What People On Medicare And Medicaid Should Know
The Centers for Medicare and Medicaid Services (CMS) is rolling out a program this summer that will provide more affordable ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The accepted providers have agreed to receive payments tied to the results-based Medicare payment model, which allows ...
Louisville companies Cornbread Hemp and Alliant Purchasing are part of a new Medicare pilot program for cannabis products.
The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...
Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results